These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8105253)

  • 21. [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].
    Poux JM; Ranger-Rogez S; Lagarde C; Benevent D; Denis F; Leroux-Robert C
    Presse Med; 1995 May 6-13; 24(17):803-6. PubMed ID: 7630869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara).
    Roukens AH; Vossen AC; Boland GJ; Verduyn W; van Dissel JT; Visser LG
    Vaccine; 2010 Jun; 28(26):4288-93. PubMed ID: 20433806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal vaccination against hepatitis B in a group of medical students.
    Brink NS; Murray AB
    S Afr Med J; 1991 Jun; 79(11):653-4. PubMed ID: 1828632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal hepatitis B vaccination in nonresponsive hemodialysis patients.
    Mettang T; Weber J; Schenk U; Machleidt C; Kuhlmann U
    Ren Fail; 1993; 15(5):655-6. PubMed ID: 8290715
    [No Abstract]   [Full Text] [Related]  

  • 26. Intradermal hepatitis B vaccine.
    Irving WL; Parsons AJ; Kurtz JB; Juel-Jensen BE
    Lancet; 1987 Sep; 2(8558):561. PubMed ID: 2887843
    [No Abstract]   [Full Text] [Related]  

  • 27. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appraisal of intradermal immunisation against hepatitis B.
    Zuckerman AJ
    Lancet; 1987 Feb; 1(8530):435-6. PubMed ID: 2880225
    [No Abstract]   [Full Text] [Related]  

  • 29. Intradermal vaccination against hepatitis B.
    Irving WL; Alder M; Kurtz JB; Juel-Jensen B
    Lancet; 1986 Dec; 2(8519):1340. PubMed ID: 2878212
    [No Abstract]   [Full Text] [Related]  

  • 30. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the Centers for Disease Control. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    JAMA; 1991 Sep; 266(10):1338-9. PubMed ID: 1831865
    [No Abstract]   [Full Text] [Related]  

  • 34. Intradermal vaccination.
    Lancet; 1983 Dec 24-31; 2(8365-66):1464-5. PubMed ID: 6140551
    [No Abstract]   [Full Text] [Related]  

  • 35. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
    Ghebrehewet S; Baxter D; Falconer M; Paver K
    Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
    Somboonsilp W; Eiam-Ong S; Tungsanga K; Tirawatanapong T
    J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An early-type hypersensitivity (ETH) to hepatitis B surface antigen as a quick and economic screening test for a vaccination program.
    Barone P; Leonardi S; Oggiano R; Musumeci S
    Ann Ig; 1998; 10(2):121-4. PubMed ID: 9658674
    [No Abstract]   [Full Text] [Related]  

  • 40. Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine.
    Playford EG; Hogan PG; Bansal AS; Harrison K; Drummond D; Looke DF; Whitby M
    Infect Control Hosp Epidemiol; 2002 Feb; 23(2):87-90. PubMed ID: 11894838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.